Genomic mapping unlocks new insights into threatened Asian hornbills
A breakthrough in hornbill genomics offers scientists new tools to trace species history and guide conservation of four threatened Asian hornbills.
Global Biotech 12 articles
Global Biotech compares the biotechnology ecosystem across borders, following how science, capital, regulation, manufacturing and therapeutic development interact internationally. Cross-border licensing, investment flows, regional innovation hubs and global development strategies belong when more than one market or regulatory system is central to the story. Country-specific news stays in regional sections unless the value of the analysis comes from international comparison or cross-border consequences.
Australian government funds international CAR-T clinical trials for children
A new five million dollar grant from the Australian Government will bring international CAR-T clinical trials for childhood cancer to Australia, reducing the need for families to seek treatment overseas.
Uzbekistan plans Biome center for cell technologies and genomics
Uzbekistan is moving ahead with a Biome center dedicated to cell technologies, genomics, and biobanking, aiming to strengthen its position in advanced bioscience research.
UK and Israel pursue new science and tech partnerships despite political tensions
British Ambassador Simon Walters is working to connect Israel with the Oxford-Cambridge Growth Corridor, aiming to build new partnerships in genomics, agri-tech, AI, and clean tech, even as political disagreements continue.
CAR-T therapy transforms relapsed lymphoma into a race for treatment access
CAR-T therapy offers a lifeline for patients with relapsed blood cancers, but the real challenge is getting the treatment before time and logistics run out.
Gujarat Themis Biosyn completes Rs 1,200 crore acquisition of MicroBiopharm Japan
Gujarat Themis Biosyn Limited has closed its Rs 1,200 crore deal to acquire MicroBiopharm Japan, gaining new biologics capabilities and a direct presence in regulated global markets.
AI designs new viruses to fight bacteria and rewrites the rules of biotechnology
Artificial intelligence has crossed a threshold in biotechnology by designing functional viruses that target bacteria, opening vast opportunities and urgent responsibilities for India and the world.
Gene edited rice faces backlash as coalition demands urgent policy reversal in India
A coalition of scientists and farmers is urging the Indian government to stop gene edited rice, warning of health, environmental, and economic risks, and calling for a return to Dr Richharia’s sustainable approach to agriculture.
Andrew Dauber honored for advances in pediatric endocrinology research
Andrew Dauber, chief of Endocrinology at Children’s National, received the ESPE International Research Award in Marseille for his work on genetic growth disorders and precision medicine.
Holtec Nuclear delays IPO as Nscale eyes multibillion dollar debut
Holtec Nuclear abruptly postponed its $825 million IPO while Nscale filed for a potential $2 billion offering and Electra Therapeutics suffered a rare biotech IPO drop.
North Carolina biotech bets on proof before scale in a fragmented funding surge
North Carolina’s life sciences sector is taking a measured approach to growth, favoring smaller, risk-managed deals and targeted expansions, while a few major players make billion-dollar commitments.
SK Biopharmaceuticals acquires global rights to preclinical Parkinson's drug in deal with 1ST Biotherapeutics
SK Biopharmaceuticals has signed a licensing and equity agreement with 1ST Biotherapeutics, gaining exclusive global rights to a preclinical Parkinson's disease candidate with a dual-inhibition mechanism.